Structure |
Chemical Name |
CAS |
MF |
![Acarbose Impurity D](/) |
Acarbose Impurity D |
|
|
![Acarbose Impurity D](/) |
Acarbose Impurity D |
|
|
![Acarbose Impurity C](/) |
Acarbose Impurity C |
|
|
![Acarbose Impurity C](/) |
Acarbose Impurity C |
|
|
![Nintedanib Impurity G (Intedanib Impurity G)](/) |
Nintedanib Impurity G (Intedanib Impurity G) |
|
|
![Canagliflozin alpha-Isomer Impurity](/) |
Canagliflozin alpha-Isomer Impurity |
|
|
![Dapagliflozin Impurity 4](/) |
Dapagliflozin Impurity 4 |
|
|
![Isavuconazole Impurity 9](/) |
Isavuconazole Impurity 9 |
|
|
![Apremilast Impurity E](/) |
Apremilast Impurity E |
|
|
![Bisoprolol EP Impurity N](/CAS/20180629/GIF/1346601-75-9.gif) |
Bisoprolol EP Impurity N |
1346601-75-9 |
C17H29NO4 |
![Rosuvastatin EP Impurity J](/) |
Rosuvastatin EP Impurity J |
|
|
![Bosutinib Impurity](/CAS/20180808/GIF/380843-12-9.gif) |
Bosutinib Impurity |
380843-12-9 |
C19H15Cl2N3O3 |
![4-(4-Chloro-pyrimidin-2-ylamino)-benzamide](/CAS/20180629/GIF/CB03121229.gif) |
4-(4-Chloro-pyrimidin-2-ylamino)-benzamide |
1629023-90-0 |
C18H12N6 |
![Methyl 4-(4-fluorophenyl)-6-isopropyl-2-oxo-1,2,3,4-tetrahydropyrimidine-5-carboxylate](/CAS/20180629/GIF/488798-36-3.gif) |
Methyl 4-(4-fluorophenyl)-6-isopropyl-2-oxo-1,2,3,4-tetrahydropyrimidine-5-carboxylate |
488798-36-3 |
C15H17FN2O3 |
![Nateglinide Methyl Ester](/CAS/20180808/GIF/105746-47-2.gif) |
Nateglinide Methyl Ester |
105746-47-2 |
C20H29NO3 |
![(1S,2S,3R,5S)-3-(5-Amino-6-chloro-2-(propylthio)pyrimidin-4-ylamino)-5-(2-hydroxyethoxy)cyclopentane-1,2-diol](/CAS/20180629/GIF/1402150-32-6.gif) |
(1S,2S,3R,5S)-3-(5-Amino-6-chloro-2-(propylthio)pyrimidin-4-ylamino)-5-(2-hydroxyethoxy)cyclopentane-1,2-diol |
1402150-32-6 |
C14H23ClN4O4S |
![Lamivudine impurity 6](/CAS/20210111/GIF/147126-64-5.gif) |
Lamivudine impurity 6 |
147126-64-5 |
C14H24O4S |
![Palbociclib Impurity G](/) |
Palbociclib Impurity G |
|
|
![Trifluridine Impurity 1](/) |
Trifluridine Impurity 1 |
|
|
![Tigecycline Impurity 1](/CAS/20180906/GIF/1138343-10-8.gif) |
Tigecycline Impurity 1 |
1138343-10-8 |
C29H38N5O10+ |
![Cephalexin Impurity 3](/CAS/20200119/GIF/CB03127928.gif) |
Cephalexin Impurity 3 |
|
C16H17N3O4S |
![Vonoprazan Impurity 2](/) |
Vonoprazan Impurity 2 |
|
|
![Sildenafil Impurity F](/CAS/20200119/GIF/263897-18-3.gif) |
Sildenafil Impurity F |
263897-18-3 |
C21H28N6O4S |
![Cetirizine impurity 5](/CAS/20200119/GIF/CB03128071.gif) |
Cetirizine impurity 5 |
|
C21H25ClN2O3 |
![Valsartan impurity 35](/CAS/20180629/GIF/CB03128107.gif) |
Valsartan impurity 35 |
1283097-98-2 |
C24H29N5O3 |
![Valsartan Impurity 16](/CAS/20200119/GIF/CB03128112.gif) |
Valsartan Impurity 16 |
2680532-87-8 |
C7H16N2O |
![Istradefylline Impurity 1](/) |
Istradefylline Impurity 1 |
|
|
![Everolimus impurity 4](/) |
Everolimus impurity 4 |
|
|
![Ambrisentan Impurity 3](/CAS/20210305/GIF/178306-49-5.gif) |
Ambrisentan Impurity 3 |
178306-49-5 |
C16H16O4 |
![Avanafil Impurity 9](/) |
Avanafil Impurity 9 |
|
|
![Erlotinib Imp.15](/) |
Erlotinib Imp.15 |
|
|
![Erlotinib Imp.5](/) |
Erlotinib Imp.5 |
|
|
![Ticagrelor Imp.Q](/) |
Ticagrelor Imp.Q |
|
|
![Avibactam Impurity 15](/CAS/20180906/GIF/1416134-60-5.gif) |
Avibactam Impurity 15 |
1416134-60-5 |
C15H20N2O3 |
![(1R,3R)-Solifenacin Succinate 2](/CAS/20180808/GIF/740780-79-4.gif) |
(1R,3R)-Solifenacin Succinate 2 |
740780-79-4 |
C23H26N2O2 |
![Daptomycin Impurity 3](/) |
Daptomycin Impurity 3 |
|
|
![Duluvir impurity 1](/) |
Duluvir impurity 1 |
|
|
![Lincomycin sulfoxide Impurity D](/) |
Lincomycin sulfoxide Impurity D |
|
|
![Lornoxicam Impurity 4](/) |
Lornoxicam Impurity 4 |
|
|
![Netupitant Impurity 3](/) |
Netupitant Impurity 3 |
|
|
![nicergoline impurity B](/) |
nicergoline impurity B |
|
|
![Tacrolimus Impurity B](/) |
Tacrolimus Impurity B |
|
|
![Oxytetracycline Impurity](/) |
Oxytetracycline Impurity |
|
|
![1H-Benz[de]isoquinolin-1-one,2,4,5,6-tetrahydro-2-[(3S)-1-oxido-1-azabicyclo[2.2.2]oct-3-yl]-](/CAS/20180629/GIF/1021456-82-5.gif) |
1H-Benz[de]isoquinolin-1-one,2,4,5,6-tetrahydro-2-[(3S)-1-oxido-1-azabicyclo[2.2.2]oct-3-yl]- |
1021456-82-5 |
C19H22N2O2 |
![Erlotinib Impurity 20](/CAS/20200611/GIF/236750-62-2.gif) |
Erlotinib Impurity 20 |
236750-62-2 |
C13H20N2O5 |
![Afatinib Impurity 17](/CAS/20210111/GIF/1870880-09-3.gif) |
Afatinib Impurity 17 |
1870880-09-3 |
C20H18Cl2FN5O |
![6-amino-1,5-dimethylpyrimidine-2,4(1H,3H)-dione](/CAS/20180629/GIF/63959-47-7.gif) |
6-amino-1,5-dimethylpyrimidine-2,4(1H,3H)-dione |
63959-47-7 |
C6H9N3O2 |
![Ciclosporin impurity](/) |
Ciclosporin impurity |
|
|
![Atomoxetine impurity](/CAS/20211123/GIF/42064-62-0.gif) |
Atomoxetine impurity |
42064-62-0 |
C18H24ClNO |
![Conivaptan impurity](/CAS/20211123/GIF/1129433-63-1.gif) |
Conivaptan impurity |
1129433-63-1 |
C32H26N4O2 |
![Terazosin impurity](/CAS/20180629/GIF/1260939-66-9.gif) |
Terazosin impurity |
1260939-66-9 |
C19H27N5O4 |
![ent-Ivabradine Hydrochloride](/CAS/20180808/GIF/167072-91-5.gif) |
ent-Ivabradine Hydrochloride |
167072-91-5 |
C27H36N2O5 |
![SofosBuvir Impurity 2](/) |
SofosBuvir Impurity 2 |
|
|
![isopropyl 2-(3-cyano-4-isobutoxyphenyl)-4-methylthiazole-5-carboxylate](/CAS/20180629/GIF/1346238-10-5.gif) |
isopropyl 2-(3-cyano-4-isobutoxyphenyl)-4-methylthiazole-5-carboxylate |
1346238-10-5 |
C19H22N2O3S |
![1,3-diphenylpropan-1-ol](/CAS/20180629/GIF/14097-24-6.gif) |
1,3-diphenylpropan-1-ol |
14097-24-6 |
C15H16O |
![Canagliflozin Impurity 21](/) |
Canagliflozin Impurity 21 |
|
|
![Canagliflozin Impurity 7](/) |
Canagliflozin Impurity 7 |
|
|
![Dolutegravir Glucoside](/) |
Dolutegravir Glucoside |
|
|
![Fasudil Impurity 5](/CAS/20200515/GIF/2044702-91-0.gif) |
Fasudil Impurity 5 |
2044702-91-0 |
C10H9NO3S |
![Ibrutinib Impurity 10](/) |
Ibrutinib Impurity 10 |
|
|
![Lesinurad Impurity 4](/CAS/20180808/GIF/1533519-97-9.gif) |
Lesinurad Impurity 4 |
1533519-97-9 |
C17H14BrN3O2S |
![1-(5-(2-fluorophenyl)-1H-pyrrol-3-yl)-N-methylmethanamine](/CAS/20180629/GIF/1610043-62-3.gif) |
1-(5-(2-fluorophenyl)-1H-pyrrol-3-yl)-N-methylmethanamine |
1610043-62-3 |
C12H13FN2 |
![FeBuxostat Impurity 26](/CAS/20210111/GIF/1886961-39-2.gif) |
FeBuxostat Impurity 26 |
1886961-39-2 |
C14H12N2O3S |
![Rivaroxaban degradation impurity 2](/) |
Rivaroxaban degradation impurity 2 |
|
|
![(S)-methyl 2-(((S)-(perfluorophenoxy)(phenoxy)phosphoryl)amino)propanoate](/CAS/20180527/GIF/1911578-88-5.gif) |
(S)-methyl 2-(((S)-(perfluorophenoxy)(phenoxy)phosphoryl)amino)propanoate |
1911578-88-5 |
C16H13F5NO5P |
![(R)-3-((R)-2-cyclopentyl-2-hydroxy-2-phenylacetoxy)-1,1-dimethylpyrrolidin-1-ium](/CAS/20180629/GIF/CB03159057.gif) |
(R)-3-((R)-2-cyclopentyl-2-hydroxy-2-phenylacetoxy)-1,1-dimethylpyrrolidin-1-ium |
|
C19H28NO3+ |
![5-fluoro-1-((2R,5S)-2-(hydroxymethyl)-1,3-oxathiolan-5-yl)pyrimidine-2,4(1H,3H)-dione](/CAS/20180629/GIF/CB03159062.gif) |
5-fluoro-1-((2R,5S)-2-(hydroxymethyl)-1,3-oxathiolan-5-yl)pyrimidine-2,4(1H,3H)-dione |
|
C8H9FN2O4S |
![Amlodipine Impurity 13](/CAS/20180629/GIF/CB03159163.gif) |
Amlodipine Impurity 13 |
|
C26H31ClN2O8S |
![Apixaban Impurity 13](/) |
Apixaban Impurity 13 |
|
|
![Aripiprazole-Impurity 17](/CAS/20200515/GIF/1424857-89-5.gif) |
Aripiprazole-Impurity 17 |
1424857-89-5 |
C16H17Cl4N3 |
![Aripiprazole-Impurity 17](/CAS/20200515/GIF/1424857-89-5.gif) |
Aripiprazole-Impurity 17 |
1424857-89-5 |
C16H17Cl4N3 |
![Cefathiamidine Impurity 3](/CAS/20180808/GIF/1417570-09-2.gif) |
Cefathiamidine Impurity 3 |
1417570-09-2 |
C17H26N4O4S2 |
![Rivaroxaban Impurity 34](/) |
Rivaroxaban Impurity 34 |
|
|
![Rivaroxaban Impurity 43](/CAS/20210111/GIF/2197189-38-9.gif) |
Rivaroxaban Impurity 43 |
2197189-38-9 |
C19H18ClN3O6S |
![(S)-thiazolidine-4-carboxylic acid (D)](/CAS/20180629/GIF/CB03161584.gif) |
(S)-thiazolidine-4-carboxylic acid (D) |
|
C4H7NO2S |
![Clindamycin 2,4-Diphosphate](/CAS/20180808/GIF/1309048-48-3.gif) |
Clindamycin 2,4-Diphosphate |
1309048-48-3 |
C18H35ClN2O11P2S |
![1-(5,6,7,8-tetrahydronaphthalen-1-yl)ethan-1-amine hydrochloride](/CAS/20180527/GIF/154377-56-7.gif) |
1-(5,6,7,8-tetrahydronaphthalen-1-yl)ethan-1-amine hydrochloride |
154377-56-7 |
C12H17N |
![Abiraterone Impurity 4](/CAS/20211123/GIF/2118-32-3.gif) |
Abiraterone Impurity 4 |
2118-32-3 |
C23H34O2 |
![Brexpiprazole Impurity 20](/CAS/20210111/GIF/1420987-85-4.gif) |
Brexpiprazole Impurity 20 |
1420987-85-4 |
C20H20N2S2 |
![Cabozantinib Impurity D](/) |
Cabozantinib Impurity D |
|
|
![4,9-diisobutyl-1,6-diazecane-2,7-dione](/CAS/20180527/GIF/1990538-03-8.gif) |
4,9-diisobutyl-1,6-diazecane-2,7-dione |
1990538-03-8 |
C16H30N2O2 |
![ethyl 7-chloro-6-fluoro-4-oxo-1,4-dihydroquinoline-3-carboxylate](/CAS/20180527/GIF/75073-15-3.gif) |
ethyl 7-chloro-6-fluoro-4-oxo-1,4-dihydroquinoline-3-carboxylate |
75073-15-3 |
C12H9ClFNO3 |
![5-phenyl-1H-pyrrole-3-carbonitrile](/CAS/20180527/GIF/122453-85-4.gif) |
5-phenyl-1H-pyrrole-3-carbonitrile |
122453-85-4 |
C11H8N2 |
![Apixaban Impurity 42](/CAS/20200119/GIF/132577-23-2.gif) |
Apixaban Impurity 42 |
132577-23-2 |
C12H14N2O4 |
![Apixaban Impurity 42](/CAS/20200119/GIF/132577-23-2.gif) |
Apixaban Impurity 42 |
132577-23-2 |
C12H14N2O4 |
![2-METHYL-4,5-DINITRO-1H-IMIDAZOLE](/StructureFile/ChemBookStructure3/GIF/CB0319715.gif) |
2-METHYL-4,5-DINITRO-1H-IMIDAZOLE |
19183-16-5 |
C4H4N4O4 |
![1-Piperazineethanol, a-[(2-methoxyphenoxy)methyl]-](/CAS/GIF/162712-35-8.gif) |
1-Piperazineethanol, a-[(2-methoxyphenoxy)methyl]- |
162712-35-8 |
C14H22N2O3 |
![2(1H)-Pyrimidinone,4-amino-1-b-D-arabinofuranosyl-, 3-oxide](/CAS/20180527/GIF/30902-36-4.gif) |
2(1H)-Pyrimidinone,4-amino-1-b-D-arabinofuranosyl-, 3-oxide |
30902-36-4 |
C9H13N3O6 |
![3,5-Pyridinedicarboxylicacid, 4-(2-chlorophenyl)-1,4-dihydro-2,6-dimethyl-, 3,5-diethyl ester](/CAS/20180527/GIF/34148-67-9.gif) |
3,5-Pyridinedicarboxylicacid, 4-(2-chlorophenyl)-1,4-dihydro-2,6-dimethyl-, 3,5-diethyl ester |
34148-67-9 |
C19H22ClNO4 |
![1-Propanamine,3-(dibenz[b,e]oxepin-11(6H)-ylidene)-N,N-dimethyl-, hydrochloride (1:1), (3Z)-](/CAS/20211123/GIF/25127-31-5.gif) |
1-Propanamine,3-(dibenz[b,e]oxepin-11(6H)-ylidene)-N,N-dimethyl-, hydrochloride (1:1), (3Z)- |
25127-31-5 |
C19H22ClNO |
![Phenol, 4-(hydroxyamino)-](/CAS/20200119/GIF/3505-87-1.gif) |
Phenol, 4-(hydroxyamino)- |
3505-87-1 |
C6H7NO2 |
![Benzoic acid, 4-(3-hydroxy-1-propenyl)-, ethyl ester](/CAS/20180527/GIF/89113-43-9.gif) |
Benzoic acid, 4-(3-hydroxy-1-propenyl)-, ethyl ester |
89113-43-9 |
C12H14O3 |
![1-((2S,3R,4R,5R)-3-fluoro-4-hydroxy-5-(hydroxymethyl)-3-methyltetrahydrofuran-2-yl)pyrimidine-2,4(1H,3H)-dione](/CAS/20180527/GIF/2041584-99-8.gif) |
1-((2S,3R,4R,5R)-3-fluoro-4-hydroxy-5-(hydroxymethyl)-3-methyltetrahydrofuran-2-yl)pyrimidine-2,4(1H,3H)-dione |
2041584-99-8 |
C10H13FN2O5 |
![2-(7-methoxy-3,4-dihydronaphthalen-1-yl)ethan-1-amine](/CAS/20180527/GIF/1353428-89-3.gif) |
2-(7-methoxy-3,4-dihydronaphthalen-1-yl)ethan-1-amine |
1353428-89-3 |
C13H17NO |
![2-(7-methoxy-3,4-dihydronaphthalen-1-yl)ethan-1-amine](/CAS/20180527/GIF/1353428-89-3.gif) |
2-(7-methoxy-3,4-dihydronaphthalen-1-yl)ethan-1-amine |
1353428-89-3 |
C13H17NO |
![Dapoxetine Impurity 13](/CAS/20211123/GIF/156453-50-8.gif) |
Dapoxetine Impurity 13 |
156453-50-8 |
C19H18O2 |
![Terbutaline Impurity 4](/CAS/20181212/GIF/52144-92-0.gif) |
Terbutaline Impurity 4 |
52144-92-0 |
C33H35NO3 |
![5-bromo-4-chloro-N-cyclopentylpyrimidin-2-amine](/CAS/20180527/GIF/1823404-28-9.gif) |
5-bromo-4-chloro-N-cyclopentylpyrimidin-2-amine |
1823404-28-9 |
C9H11BrClN3 |
![(3R,5S,E)-7-(4-(4-fluorophenyl)-2-((2-hydroxy-N,2-dimethylpropyl)sulfonamido)-6-isopropylpyrimidin-5-yl)-3,5-dihydroxyhept-6-enoic acid](/CAS/20180527/GIF/1714147-47-3.gif) |
(3R,5S,E)-7-(4-(4-fluorophenyl)-2-((2-hydroxy-N,2-dimethylpropyl)sulfonamido)-6-isopropylpyrimidin-5-yl)-3,5-dihydroxyhept-6-enoic acid |
1714147-47-3 |
C25H36CaFN3O7S |
![delphinidin 3-O-beta-D-glucoside](/CAS/20180808/GIF/50986-17-9.gif) |
delphinidin 3-O-beta-D-glucoside |
50986-17-9 |
C21H21O12+ |